标题
siRNA therapeutics: a clinical reality
作者
关键词
-
出版物
Science China-Life Sciences
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-05-03
DOI
10.1007/s11427-018-9438-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety, tolerability, and pharmacokinetics of BMS-986263/ND-L02-s0201, a novel targeted lipid nanoparticle delivering HSP47 siRNA, in healthy participants: A randomised, placebo-controlled, double-blind, phase 1 study
- (2018) B. Soule et al. JOURNAL OF HEPATOLOGY
- Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
- (2018) Donald J. Foster et al. MOLECULAR THERAPY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
- (2018) Aaron D. Springer et al. Nucleic Acid Therapeutics
- Circular siRNAs for Reducing Off-Target Effects and Enhancing Long-Term Gene Silencing in Cells and Mice
- (2018) Liangliang Zhang et al. Molecular Therapy-Nucleic Acids
- Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy
- (2017) Xiaoding Xu et al. NANO LETTERS
- A drug-delivery strategy for overcoming drug resistance in breast cancer through targeting of oncofetal fibronectin
- (2017) Phei Er Saw et al. Nanomedicine-Nanotechnology Biology and Medicine
- Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
- (2017) Jayaprakash K. Nair et al. NUCLEIC ACIDS RESEARCH
- Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement.
- (2017) A. Cervantes et al. JOURNAL OF CLINICAL ONCOLOGY
- Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy
- (2016) Xiaoding Xu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Abstract 2925: Anti-tumor activity of a MYC-targeting dicer substrate siRNA in combination with BRD4/CDK7 inhibitors
- (2016) Edmond Chipumuro et al. CANCER RESEARCH
- Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
- (2016) Victor Kotelianski et al. International Journal of Nanomedicine
- “Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy
- (2016) Isabel Conceição et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
- (2016) Jake Dunning et al. PLOS MEDICINE
- Preclinical and clinical development of siRNA-based therapeutics
- (2015) Gulnihal Ozcan et al. ADVANCED DRUG DELIVERY REVIEWS
- Evolving landscape in the management of transthyretin amyloidosis
- (2015) Philip N. Hawkins et al. ANNALS OF MEDICINE
- Antibody-Mediated Delivery of Anti-KRAS-siRNA In Vivo Overcomes Therapy Resistance in Colon Cancer
- (2015) S. Baumer et al. CLINICAL CANCER RESEARCH
- Harnessing RNA Interference for Therapy
- (2015) Judy Lieberman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical experiences with systemically administered siRNA-based therapeutics in cancer
- (2015) Jonathan E. Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- Knocking down disease: a progress report on siRNA therapeutics
- (2015) Anders Wittrup et al. NATURE REVIEWS GENETICS
- RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
- (2015) Talia Golan et al. Oncotarget
- siRNA Versus miRNA as Therapeutics for Gene Silencing
- (2015) Jenny K W Lam et al. Molecular Therapy-Nucleic Acids
- Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery
- (2014) Aristides D. Tagalakis et al. BIOMATERIALS
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phase I First-in-Humans Trial of ALN-TTRsc, a Novel RNA Interference Therapeutic for the Treatment of Familial Amyloidotic Cardiomyopathy (FAC)
- (2013) Tracy Zimmermann et al. JOURNAL OF CARDIAC FAILURE
- Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
- (2013) Kevin Fitzgerald et al. LANCET
- Adsorption and Release of siRNA from Porous Silica
- (2013) Jeremy L. Steinbacher et al. LANGMUIR
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
- (2013) Teresa Coelho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guideline of transthyretin-related hereditary amyloidosis for clinicians
- (2013) Yukio Ando et al. Orphanet Journal of Rare Diseases
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Abstract 2829: Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase 1
- (2012) Sean C. Semple et al. CANCER RESEARCH
- RNA-Based Therapeutics: Current Progress and Future Prospects
- (2012) John C. Burnett et al. CHEMISTRY & BIOLOGY
- THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis
- (2012) Teresa Coelho et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
- (2012) Steven M. Johnson et al. JOURNAL OF MOLECULAR BIOLOGY
- siRNA-optimized Modifications for Enhanced In Vivo Activity
- (2012) Denise M Kenski et al. Molecular Therapy-Nucleic Acids
- Current progress of siRNA/shRNA therapeutics in clinical trials
- (2011) John C. Burnett et al. Biotechnology Journal
- Nanocarriers: a tool to overcome biological barriers in siRNA delivery
- (2011) Avnesh Kumari et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors
- (2011) Dirk Strumberg et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids
- (2011) Marija Tadin-Strapps et al. JOURNAL OF LIPID RESEARCH
- RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus
- (2010) Martin R. Zamora et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib
- (2010) M. Koldehoff et al. HAEMATOLOGICA
- Promise and Challenge of RNA Interference–Based Therapy for Cancer
- (2010) Fabio Petrocca et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
- (2010) J. DeVincenzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy
- (2009) R. Alvarez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The ups and downs of Myc biology
- (2009) Laura Soucek et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
- (2009) Mark E. Davis MOLECULAR PHARMACEUTICS
- First-in-human Mutation-targeted siRNA Phase Ib Trial of an Inherited Skin Disorder
- (2009) Sancy A Leachman et al. MOLECULAR THERAPY
- Layer-by-Layer Assembled Gold Nanoparticles for siRNA Delivery
- (2009) Asmaa Elbakry et al. NANO LETTERS
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
- (2009) Aimee L. Jackson et al. NATURE REVIEWS DRUG DISCOVERY
- siRNA and Innate Immunity
- (2009) Marjorie Robbins et al. OLIGONUCLEOTIDES
- Comparative Study of Intravitreal Bevacizumab (Avastin) versus Ranibizumab (Lucentis) in the Treatment of Neovascular Age-Related Macular Degeneration
- (2009) Gennady Landa et al. OPHTHALMOLOGICA
- Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth
- (2009) W. G. Cho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COMBINATION THERAPY USING THE SMALL INTERFERING RNA BEVASIRANIB
- (2009) LAWRENCE SINGERMAN RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2009) KIMBERLY E. STEPIEN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- siRNA Conjugate Delivery Systems
- (2008) Ji Hoon Jeong et al. BIOCONJUGATE CHEMISTRY
- Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
- (2008) M. Aleku et al. CANCER RESEARCH
- Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
- (2008) Marjorie Robbins et al. HUMAN GENE THERAPY
- Delivery Vehicles for Small Interfering RNA In Vivo
- (2008) Antonin R. de Fougerolles HUMAN GENE THERAPY
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
- (2008) Mark E. Kleinman et al. NATURE
- Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone
- (2008) Yasushi Sato et al. NATURE BIOTECHNOLOGY
- RNA major groove modifications improve siRNA stability and biological activity
- (2008) Montserrat Terrazas et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started